158 related articles for article (PubMed ID: 20082450)
21. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
22. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM
Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639
[TBL] [Abstract][Full Text] [Related]
23. Treatment of locally advanced non-small cell lung cancer with combination of chemotherapy and radiation.
Martins RG
Semin Respir Crit Care Med; 2005 Jun; 26(3):273-7. PubMed ID: 16052428
[TBL] [Abstract][Full Text] [Related]
24. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
Sandler AB
Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
[TBL] [Abstract][Full Text] [Related]
25. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
Brock MV; Hooker CM; Syphard JE; Westra W; Xu L; Alberg AJ; Mason D; Baylin SB; Herman JG; Yung RC; Brahmer J; Rudin CM; Ettinger DS; Yang SC
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):64-72. PubMed ID: 15632826
[TBL] [Abstract][Full Text] [Related]
26. [Treatment strategy for neuroendocrine carcinoma of the lung].
Kawase A; Nagai K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1619-22. PubMed ID: 19838019
[TBL] [Abstract][Full Text] [Related]
27. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
Kubota K
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
[TBL] [Abstract][Full Text] [Related]
28. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
[TBL] [Abstract][Full Text] [Related]
30. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
[TBL] [Abstract][Full Text] [Related]
31. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
[TBL] [Abstract][Full Text] [Related]
33. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
35. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
[TBL] [Abstract][Full Text] [Related]
36. Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years.
Munzuroglu F; Erturan S; Oz B; Dincbas FO; Demir G
J BUON; 2009; 14(2):313-6. PubMed ID: 19650185
[TBL] [Abstract][Full Text] [Related]
37. Management of small cell lung cancer in elderly.
Satoh H; Ishikawa H; Funayama Y; Yamashita YT; Kamma H; Ohtsuka M; Sekizawa K
Anticancer Res; 1999; 19(5C):4507-10. PubMed ID: 10650801
[TBL] [Abstract][Full Text] [Related]
38. [International consensus for lung cancer treatment].
Naruse I; Saijo N
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():451-9. PubMed ID: 9369922
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA
Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195
[TBL] [Abstract][Full Text] [Related]
40. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]